Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers in Subjects With Secondary Progressive Multiple Sclerosis

NCT02683863 is registered in ClinicalTrials.gov with Multiple Sclerosis Center of Northeastern New York as lead sponsor.

NCT NCT02683863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02683863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers in Subjects With Secondary Progressive Multiple Sclerosis
Lead sponsor
Multiple Sclerosis Center of Northeastern New York
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2015
Completion date
January 31, 2017
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis